Oleyl Sulfate

Oleyl Sulfate

SCHEMBL430287

CC(O)N(C(C)O)C(C)O.CCCCCCCC/C=C\CCCCCCCCOS(=O)(=O)O

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 2/20 0.44
EPHX2 P34913 4/20 0.43
FAAH O00519 1/20 0.42
LPAR1 Q92633 2/20 0.41
LPAR2 Q9HBW0 2/20 0.41
LPAR3 Q9UBY5 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL430869 0.91 CA1 (0.47) EPHX2
SCHEMBL2324900 0.91 CA1 (0.47) EPHX2
SCHEMBL378934 0.91 CA1 (0.47) EPHX2
Octadecyl Sulfate SCHEMBL3963774 0.91 CA1 (0.47) EPHX2
SCHEMBL2323499 0.91 CA1 (0.47) EPHX2
SCHEMBL8425908 0.91 CA1 (0.47) EPHX2
SCHEMBL97774 0.91 CA1 (0.47) EPHX2
SCHEMBL4292980 0.91 CA1 (0.47) EPHX2
Sulfuric Acid SCHEMBL8526889 0.90 CA1 (0.46) EPHX2
Ammonia Solution, Strong SCHEMBL11778710 0.90 CA1 (0.46) EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3610849-B1 METHOD FOR REMOVING KERATOTIC PLUGS KAO CORP (JP) 2025-09-17 EP disclosed
EP-4023304-B1 A KERATOTIC PLUG-REMOVING COMPOSITION KAO CORP (JP) 2025-08-27 EP disclosed
EP-3610848-B1 SKIN CLEANSING COMPOSITION KAO CORP (JP) 2025-08-27 EP disclosed
US-11975086-B2 Method for removing keratotic plugs KAO CORPORATION (JP) 2024-05-07 US disclosed
EP-4269549-A2 SKIN CLEANSING COMPOSITIONS Kao Corporation (JP) 2023-11-01 EP disclosed
EP-3610850-B1 SKIN CLEANSING COMPOSITIONS KAO CORP (JP) 2023-10-25 EP disclosed
CN-116847871-A Skin care compositions and methods of use 现代牧场股份有限公司 2023-10-03 CN disclosed
CN-116785188-A Skin cleansing composition 花王株式会社 2023-09-22 CN disclosed
CN-110520102-B Skin cleansing composition 花王株式会社 2023-08-22 CN disclosed
CN-110494120-B Method for removing corner bolts 花王株式会社 2023-07-18 CN disclosed
US-20060222616-A1 Cosmetic composition comprising a and a lipopeptide KANEKA CORPORATION (JP) 2006-10-05 US disclosed
EP-1689494-A1 AGENT FOR SKIN EXTERNAL USE CONTAINING SALT OF ASCORBIC ACID DERIVATIVE, METHOD FOR STABILIZING THE AGENT FOR SKIN EXTERNAL USE, AND STABILIZER Showa Denko K.K. (JP) 2006-08-16 EP disclosed
EP-1660025-A1 COSMETIC COMPOSITION CONTAINING A POLYOXYETHYL COMBINATION AND A LIPOPEPTIDE Showa Denko K.K. (JP) 2006-05-31 EP disclosed
WO-2005102267-A1 AGENT FOR SKIN EXTERNAL USE CONTAINING TOCOPHEROL DERIVATIVE, ASCORBIC ACID DERIVATIVE AND SURFACE ACTIVE AGENT HAVING LIPOPEPTIDE STRUCTURE SHOWA DENKO K.K. (JP) 2005-11-03 WO disclosed
WO-2005094777-A1 EXTERNAL PREPARATION FOR SKIN SHOWA DENKO K.K. (JP) 2005-10-13 WO disclosed
WO-2005095462-A1 MOISTURE RETENTION POLYMER COMPOUND SHOWA DENKO K.K. (JP) 2005-10-13 WO disclosed
US-20050220744-A1 Polysaccharide/functional compound complex SHOWA DENKO K.K. 2005-10-06 US disclosed
WO-2005089708-A1 OIL-IN-WATER EMULSIFIED COMPOSITION, AND EXTERNAL PREPARATION FOR SKIN AND COSMETICS USING THE COMPOSITION SHOWA DENKO K.K. (JP) 2005-09-29 WO disclosed
WO-2005034903-A1 AGENT FOR SKIN EXTERNAL USE CONTAINING SALT OF ASCORBIC ACID DERIVATIVE, METHOD FOR STABILIZING THE AGENT FOR SKIN EXTERNAL USE, AND STABILIZER SHOWA DENKO K.K. (JP) 2005-04-21 WO disclosed
WO-2005020950-A1 COSMETIC COMPOSITION COMPRISING A AND A LIPOPEPTIDE SHOWA DENKO K.K. (JP) 2005-03-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11975086-B2 Method for removing keratotic plugs PAM, MUC1, CUTA PPARA 722/4885EPHX2 781/4885FAAH 2040/4885
US-20060222616-A1 Cosmetic composition comprising a and a lipopeptide CUTA, SMURF1, FABP4 PPARA 123/4885EPHX2 595/4885FAAH 99/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.